IRIS
LIGUORI, CLAUDIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 27.262
AS - Asia 5.159
EU - Europa 3.496
SA - Sud America 771
AF - Africa 112
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 10
Totale 36.823
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 27.097
SG - Singapore 2.839
CN - Cina 832
IT - Italia 803
BR - Brasile 649
RU - Federazione Russa 546
HK - Hong Kong 426
VN - Vietnam 396
IE - Irlanda 385
DE - Germania 352
UA - Ucraina 268
FR - Francia 255
GB - Regno Unito 248
KR - Corea 175
FI - Finlandia 156
JP - Giappone 147
NL - Olanda 101
SE - Svezia 97
CA - Canada 94
IN - India 83
PL - Polonia 78
ID - Indonesia 56
AR - Argentina 55
MX - Messico 46
AT - Austria 41
BD - Bangladesh 36
ES - Italia 35
ZA - Sudafrica 35
CZ - Repubblica Ceca 28
TR - Turchia 25
EG - Egitto 24
BE - Belgio 22
IQ - Iraq 22
CL - Cile 14
MA - Marocco 14
PH - Filippine 14
AU - Australia 11
CH - Svizzera 11
CO - Colombia 11
PK - Pakistan 11
SA - Arabia Saudita 11
DK - Danimarca 10
GR - Grecia 10
PY - Paraguay 10
VE - Venezuela 10
AE - Emirati Arabi Uniti 9
EC - Ecuador 9
RO - Romania 9
UZ - Uzbekistan 9
KZ - Kazakistan 8
MY - Malesia 8
DZ - Algeria 7
ET - Etiopia 7
EU - Europa 7
JM - Giamaica 7
LT - Lituania 7
TN - Tunisia 7
AZ - Azerbaigian 6
KE - Kenya 6
TW - Taiwan 6
BO - Bolivia 5
IL - Israele 5
NP - Nepal 5
PE - Perù 5
AL - Albania 4
AM - Armenia 4
HU - Ungheria 4
JO - Giordania 4
PT - Portogallo 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
KG - Kirghizistan 3
LB - Libano 3
NG - Nigeria 3
SI - Slovenia 3
TH - Thailandia 3
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GE - Georgia 2
HN - Honduras 2
HR - Croazia 2
IR - Iran 2
LK - Sri Lanka 2
MD - Moldavia 2
MK - Macedonia 2
MT - Malta 2
NI - Nicaragua 2
PA - Panama 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BM - Bermuda 1
BW - Botswana 1
CG - Congo 1
Totale 36.807
Salva come PNG Salva come JPEG
Città #
Wilmington 6.599
Houston 6.168
Woodbridge 5.723
Singapore 1.191
Fairfield 1.045
Ashburn 832
Chandler 570
San Jose 556
Seattle 439
Hong Kong 419
Cambridge 403
Ann Arbor 395
Beijing 345
Dublin 341
Medford 253
Rome 252
New York 234
Council Bluffs 215
Santa Clara 205
Jacksonville 192
The Dalles 164
Los Angeles 150
Ho Chi Minh City 122
Tokyo 122
Lawrence 121
Lauterbourg 113
Dearborn 111
Hanoi 97
Buffalo 95
Moscow 90
Helsinki 86
São Paulo 81
San Diego 79
Menlo Park 74
Milan 68
Munich 64
Colorado Springs 63
Dallas 59
London 57
Orem 48
North Bergen 47
Zhengzhou 47
Boardman 45
Kraków 44
Norwalk 42
Chicago 37
Jakarta 36
Redwood City 36
Shanghai 35
Toronto 35
Seoul 31
Stockholm 31
Phoenix 30
Nuremberg 29
Brooklyn 28
Amsterdam 27
Warsaw 27
Frankfurt am Main 26
Atlanta 25
Boston 25
Chennai 25
Manchester 25
Brno 24
Johannesburg 24
Montreal 24
Redondo Beach 21
Brussels 20
Da Nang 20
Denver 20
Guangzhou 20
Durham 19
Philadelphia 19
Nanjing 18
Rio de Janeiro 18
Salt Lake City 18
Vienna 18
Belo Horizonte 17
Istanbul 17
Columbus 16
Daejeon 16
Lappeenranta 16
Monte Porzio Catone 16
Washington 16
Cairo 15
Kilburn 15
Mexico City 14
Poplar 14
Verona 14
Bologna 13
Florence 13
Mumbai 13
Naples 13
Porto Alegre 13
Biên Hòa 12
Haiphong 12
Palo Alto 12
Pune 12
Brasília 11
Miami 11
Mountain View 10
Totale 29.588
Salva come PNG Salva come JPEG
Nome #
Symptomatic nonconvulsive status epilepticus erroneously suggestive of sporadic Creutzfeldt-Jakob disease 622
Restless legs syndrome and daytime sleepiness are prominent in myotonic dystrophy type 2 580
Paucisymptomatic Marchiafava-Bignami disease with relevant diffusion-weighted MRI lesions 549
Development of collateral veins as a favorable prognostic factor for complete recovery in cerebral venous thrombosis due to Tribulus terrestris 508
Chronic dopaminergic treatment in restless legs syndrome: Does it affect the autonomic nervous system? 503
Unexpected total recovery in a patient with post-anoxic complete alpha coma predicted by recording of cortical SEPs 498
Cerebrospinal-fluid Alzheimer's Disease Biomarkers and Blood-Brain Barrier Integrity in a natural population of cognitive intact Parkinson's Disease patients. 492
Homovanillic acid in CSF of mild stage Parkinson's disease patients correlates with motor impairment 479
Obstructive sleep apnoea as a risk factor for osteopenia and osteoporosis in the male population: further data and comments 476
Continuous positive airway pressure treatment increases serum vitamin D levels in male patients with obstructive sleep apnea 472
Bilateral thalamic stroke due to nasal ephedrine and naphazoline use 470
Effects of epilepsy treatment on sleep architecture and daytime sleepiness: an evidence-based review of objective sleep metrics 467
Rapid eye movement sleep disruption and sleep fragmentation are associated with increased orexin-A cerebrospinal-fluid levels in mild cognitive impairment due to Alzheimer's disease 456
Unilateral spatial neglect and alien limb phenomenon may be early features of Creutzfeldt-Jakob disease 454
Sleep disorders in myotonic dystrophy type 2: a controlled polysomnographic study and self-reported questionnaires 448
Serotonin impairment in CSF of PD patients, without an apparent clinical counterpart 448
Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease 446
May a suspicious psychiatric disorder hide sporadic hemiplegic migraine? Genetic test as prompting factor for diagnosis 445
Optic Nerve dysfunction in obstructive sleep apnea: An electrophysiological study 445
Pure ictal sensory seizures may represent a clinical manifestation of PLEDs 439
Restless legs syndrome and poliomyelitis: New evidences of an old observation? 439
Estrogen deficiency hampers the beneficial effect of continuous positive airway pressure therapy on serum vitamin D concentrations in postmenopausal women affected by obstructive sleep apnea 439
Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer’s disease 435
Fronto-central monomorphic theta activity as EEG pattern of ictal psychosis 434
Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. 429
Effective treatment of nocturnal frontal lobe epilepsy with lacosamide: a report of two cases 429
Cerebrospinal-fluid orexin levels and daytime somnolence in frontotemporal dementia 428
CSF Biomarkers for Early Diagnosis of Synucleinopathies: Focus on Idiopathic RBD 426
Physical activity contradictorily affects bone mineral density in obstructive sleep apnea patients at different ages 425
Beta-amyloid and phosphorylated tau metabolism changes in narcolepsy over time 423
Obstructive sleep apnoea as a risk factor for osteopenia and osteoporosis in the male population 420
null 419
Sleep disorders in spinal and bulbar muscular atrophy (Kennedy's disease): a controlled polysomnographic and self-reported questionnaires study 415
Effective treatment of restless legs syndrome by safinamide in Parkinson's disease patients 410
Spasticity as an ictal pattern due to excitotoxic upper motor neuron damage 408
Catecholamine-based treatment in AD patients: expectations and delusions 408
Rotigotine effect on sleep in a de novo Parkinson's Disease patient affected by periodic limb movement disorder 407
CSF beta-amyloid levels are altered in narcolepsy: a link with the inflammatory hypothesis? 390
Multiple sleep latency test may be not sensitive in obstructive sleep apnea with comorbid narcolepsy revealed by low cerebrospinal fluid orexin levels 390
May CSF beta-amyloid and tau proteins levels be influenced by long treatment duration and stable medication in narcolepsy? 390
Rotigotine may improve sleep architecture in Parkinson's disease: a double-blind, randomized, placebo-controlled polysomnographic study. 390
Restless legs syndrome and post polio syndrome: a case-control study 387
Does continuous positive airway pressure treatment affect autonomic nervous system in patients with severe obstructive sleep apnea? 384
Lacosamide as add-on treatment of focal symptomatic epilepsy in a patient with alcoholic liver cirrhosis 383
Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study 377
When cognitive decline and depression coexist in the elderly: CSF biomarkers analysis can differentiate Alzheimer's disease from late-life depression 374
MicroRNA expression is dysregulated in narcolepsy: A new evidence? 366
Nocturnal frontal lobe epilepsy with paroxysmal arousals due to CHRNA2 loss of function 366
Daytime autonomic activity in idiopathic rapid eye movement sleep behavior disorder: a preliminary study 366
Epstein-Barr virus neuraxis infection as a trigger for central nervous system demyelinating processes: a case report 364
Effects of adjunctive perampanel on sleep quality, daytime somnolence and cognition in refractory focal epilepsy: Further data 364
Commentary: Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease 360
Obstructive sleep apnoea and bone health 353
Low Serum 25(OH)D Levels in Parkinson ’s Disease; a Non Specific Marker of Neurodegeneration? 348
Sleep-wake cycle in the Kennedy's disease: a controlled polysomnographic study and self-reported questionnaires 345
Mechanisms of action underlying the efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson's disease: central role of disease severity 339
CSF lactate levels, τ proteins, cognitive decline: a dynamic relationship in Alzheimer's disease 332
Daytime sleepiness may be an independent symptom unrelated to sleep quality in Parkinson’s disease 318
Continuous positive airway pressure treatment may improve optic nerve function in obstructive sleep apnea: An electrophysiological study 314
Sleep apnoeas may represent a reversible risk factor for amyloid-β pathology 311
Does fatigue in Parkinson’s disease correlate with autonomic nervous system dysfunction? 288
Postural and vestibular changes related to CPAP treatment in moderate-to-severe OSA patients: a 12-month longitudinal study 287
Safinamide effect on sleep disturbances and daytime sleepiness in motor fluctuating Parkinson's disease patients: A validated questionnaires-controlled study 278
Comparative Sleep Disturbances in Myotonic Dystrophy Types 1 and 2 278
Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study 278
Obstructive sleep apnea may induce orexinergic system and cerebral β-amyloid metabolism dysregulation: is it a further proof for Alzheimer's disease risk? 267
Heart rate variability in untreated newly diagnosed temporal lobe epilepsy: Evidence for ictal sympathetic dysregulation 252
Cognitive performances in patients affected by late-onset epilepsy with unknown etiology: A 12-month follow-up study 249
Cerebrospinal Fluid Orexin Levels and Nocturnal Sleep Disruption in Alzheimer's Disease Patients Showing Neuropsychiatric Symptoms 246
CSF levels of the endocannabinoid anandamide are reduced in patients with untreated narcolepsy type 1: a pilot study 245
Lacosamide may improve cognition in patients with focal epilepsy: EpiTrack to compare cognitive side effects of lacosamide and carbamazepine 240
Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer's disease course 238
Seasonality of restless legs syndrome: symptom variability in winter and summer times 215
Depressive and anxiety symptoms in patients with SARS-CoV2 infection 206
Preliminary evidence about irritability in patients with epilepsy treated by perampanel as first add-on therapy compared to levetiracetam and valproic acid 193
Hypothalamic dysfunction is related to sleep impairment and CSF biomarkers in Alzheimer’s disease 186
Sleep-Wake Cycle in Alzheimer's Disease Is Associated with Tau Pathology and Orexin Dysregulation 185
Complement system dysregulation in patients affected by Idiopathic Generalized Epilepsy and the effect of antiepileptic treatment 179
Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection 179
Preliminary evidence that vortioxetine may improve sleep quality in depressed patients with insomnia: a retrospective questionnaire analysis 177
Laterality of Auditory Dysfunction in Parkinson's Disease 177
Assessment of Psychometric Characteristics of Parkinson’s Disease Sleep Scale 2 and Analysis of a Cut-Off Score for Detecting Insomnia in Italian Patients with Parkinson’s Disease: A Validation Study 173
Obstructive sleep apnea is associated with early but possibly modifiable Alzheimer's disease biomarkers changes 168
Pitolisant for treating narcolepsy comorbid with Parkinson's disease 166
18F-FDG PET, cognitive functioning, and CSF biomarkers in patients with obstructive sleep apnoea before and after continuous positive airway pressure treatment 165
Assessment of self-reported and objective daytime sleepiness in adult-onset myotonic dystrophy type 1 154
Lateralization of cochlear dysfunction as a specific biomarker of Parkinson’s disease 149
The actigraphic documentation of circadian sleep-wake rhythm dysregulation in myotonic dystrophy type 1 147
New revolution in the assessment of cerebrospinal fluid orexin-A: Enzyme-linked immunosorbent assay! 136
Is it time to consider obstructive sleep apnea syndrome a risk factor for Alzheimer's disease? 135
The Italian version of the “frailty index” based on deficits in health: a validation study 134
Biomarkers of cerebral glucose metabolism and neurodegeneration in Parkinson's disease: a cerebrospinal fluid-based study 134
Acute care hospital at different levels of intensity: the role of Geriatrician 132
Chronic obstructive pulmonary disease and long-term mortality in elderly subjects with chronic heart failure 131
Sarcopenia: Assessment of disease burden and strategies to improve outcomes 130
Increased noradrenaline as an additional cerebrospinal fluid biomarker in PSP-like parkinsonism 125
The reverse metabolic syndrome in the elderly: Is it a “catabolic” syndrome? 121
Autonomic symptoms, cardiovascular and sudomotor evaluation in de novo type 1 narcolepsy 119
Autonomic functions in focal epilepsy: A comparison between lacosamide and carbamazepine monotherapy 115
Multidimensional frailty evaluation in elderly outpatients with chronic heart failure: A prospective study 113
Totale 32.692
Salva come PNG Salva come JPEG
Categoria #
all - tutte 102.090
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 102.090
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021287 0 0 0 0 0 0 0 0 0 0 205 82
2021/20221.427 66 90 64 35 27 71 239 41 75 110 97 512
2022/20231.563 189 137 55 164 145 348 137 108 137 28 68 47
2023/2024743 76 15 43 26 70 211 39 108 15 21 8 111
2024/20254.356 139 690 350 197 111 516 180 189 360 321 745 558
2025/20266.435 531 284 771 671 594 287 928 848 742 701 78 0
Totale 37.472